1Wallen T,Landahl S,Hedner T,et al.Brain natriuretic peptide in an elderly population[].Journal of Internal Medicine.1997
2Wright SP,Doughty RN,Gamble GD,et al.N-terminal BNP in the community diagnosis of suspected heart failure: what is an appropriate diagnostic threshold?[].European Heart Journal.2002
3Vogeser M,Jacob K.B-type natriuretic peptide(BNP)-validation of an immediate response assay[].Clinical Laboratory.2001
4Hughes D,Talwar S,Squire IB,et al.An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction[].Clinical Science.1999
5Hobbs FD,Davis RC,Roalfe AK,et al.Reliability of N-terminal probrain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations[].British Medical Journal.2002
6Maisel AS,Koon J,Krishnaswamy P,et al.Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[].American Heart Journal.2001
7Groenning BA,Nilsson JC,Sondergaard L,et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations[].European Journal of Heart Failure.2001
8Cowie MR,Struthers AD,Wood DA,et al.Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care[].The Lancet.1997
9Fox KF,Cowie MR,Wood DA,et al.The aetiological importance of coronary artery disease in new cases of heart failure[].European Heart Journal.2001
10Remes J,Miettinen H,Reunanen A,et al.Validity of clinical diagnosis of heart failure in primary health care[].European Heart Journal.1991
6Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: inci- dence, recurrence, and long-term survival in ischemic stroke sub- types:a population-based study. Stroke, 2001,32 ( 12 ) : 2735- 2740.
7Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic Diagnosis of Ischemie Stroke Subtypes With Plasma Biomarkers. Stroke, 2008,39 ( 8 ) : 2280-2287.
8Mikikallio AM, Makikallio TH, Korpelainen JT, et al. Natriuretic peptides and mortality after stroke. Stroke, 2005,36 (5):1016- 1020.
9Panteghini M. Role and importance of biochemical markers in clinical cardiology. Enr Heart J,2004,25 ( 14 ) : 1187-1196.
10Shibazaki K, Kimura K, Iguchi Y, et al. Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med ,2009,48 (5) :259-264.
